CI
ACHN

Cowen Inc’s Achillion Pharmaceuticals ACHN Stock Holding History

Cowen Inc’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,932
Closed -$97K – 475
2015
Q2 		$97K Hold
10,932
– – 0.01% 411
2015
Q1 		$108K Buy
+10,932
New +$137K 0.01% 367
2014
Q1 		– Sell
-15,000
Closed -$50K – 261
2013
Q4 		$50K Buy
15,000
+14,900
+14,900% +$43.2K 0.01% 212
2013
Q3 		$0 Buy
+100
New +$685 ﹤0.01% 302

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cowen Inc's ACHN Position: Q3 2015 in Review

Cowen Inc sold out of Achillion Pharmaceuticals (ACHN) in Q3 2015, closing a stake of 10,932 shares — an estimated $97K sold.

Cowen Inc first reported a position in ACHN in Q3 2013 and held it in 4 quarters. The position peaked at $108K in Q1 2015. 141 funds tracked by Wall St. Rank hold ACHN as of Q3 2015.

  • Cowen Inc reported no remaining Achillion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 10,932 Achillion Pharmaceuticals shares in Q3 2015, an estimated $97K.
  • Cowen Inc first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Cowen Inc's Achillion Pharmaceuticals position peaked at $108K in Q1 2015.
  • 141 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.